Clinical Trial Update: Study of Adalimumab in Patients With Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial of adalimumab in axial spondyloarthritis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Axial Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-03-06